Bringing life saving treatments to patients more quickly is a top priority for Life Sciences leaders, a critical component of that mission is underpinned by successfully managing intricate regulatory filings such as New Drug Application (NDA), Biologics License Application (BLA), and Investigational New Drug Application. The pressure to reduce submission cycle times and “Refuse to File” (RTF) risks is immense. Agentic Solutions now focus on compressing timelines at every stage, including Regulatory Operations. As generative AI becomes a transformative force in document analysis, these powerful tools must also operate with the precision, transparency, and reliability that regulatory agencies demand.
The critical assurance needed for Regulatory Operations with AI, is How can organizations leverage the power of AI to automate complex Quality Control (QC) tasks without sacrificing the rigorous accuracy and auditability mandated by global regulators? Traditional, manual methods of cross-checking data between disparate documents and verifying compliance with ever-evolving guidance are slow, error-prone, and often fail to catch subtle, costly inconsistencies.
Google Cloud helps organizations navigate this complexity through our approach to Regulatory Submissions. By leveraging Gemini LLM and a Retrieval Augmented Generation (RAG) architecture, organizations can build a customized solution that transforms QC from a passive exercise into an active, intelligent workflow.
We encourage customers to view this as a powerful deployment option for their own Google Cloud environments.
A specialized AI solution for regulatory precision and speed
The Regulatory Submission Semantic QC Auditor demonstrates how your organization can utilize Gemini and agents to build a specialized, intelligent assistant for regulatory operations, medical writing, and scientific teams.
By implementing this approach within your own Google Cloud environment you can move beyond traditional “e-validation” tools. This architecture leverages advanced Large Language Models to understand content semantics, addressing the most critical and time-consuming pain points in the submission process while allowing you to maintain full control over versioning and compliance frameworks.
-
Semantic cross-reference for inconsistency detection: The auditor automatically reads and understands content across disparate submission modules. It can detect a discrepancy between a patient count of N=620 in a clinical overview and an analysis population of 619 in a detailed study report, even if they are phrased differently. This automation handles one of the most time-consuming and error-prone aspects of manual review.
-
Dynamic, guidance-based compliance auditing: Instead of relying on hard-coded rules that quickly become obsolete, the system ingests external guidance documents (like ICH E6, FDA draft guidelines), internal standards, and uses them as a dynamic rulebook. It can instantly audit your submission against the latest, unstructured regulatory requirements—for example, flagging a safety report that misses a new, specific timeline mentioned in a recently uploaded guidance PDF.
-
Narrative coherence and tone validation: The solution goes beyond facts to analyze the logic and tone of your narrative. It verifies that high-level summaries accurately reflect the detailed evidence in technical reports, identifying potential risks like the minimization of a safety signal or an unsupported claim of efficacy. This ensures a consistent and defensible story for regulators.
-
Agentic Q&A and remediation planning: It empowers your teams with an interactive, expert assistant. Regulatory professionals can ask complex questions like, “How do I resolve this specific protocol deviation according to ICH guidelines?” and receive a comprehensive, step-by-step remediation plan complete with citations to the relevant sections of both your dossier and the regulatory guidance.
Secure regulatory excellence and innovation
Pharmaceutical information is exceptionally sensitive encompassing GxP data, non clinical and clinical trial data as well as intellectual property. The top priority is maintaining total control over data access while ensuring no data exfiltration occurs beyond the defined security perimeter, helping you meet the security and privacy requirements for your organisation. Compliance is achieved through a Shared Fate model between Google Cloud and customers. In this partnership, Google provides a secure, resilient, compliant infrastructure that aids your security goals. Although your organization is still responsible for validating that applications and processes comply with 21 CFR Part 11, GxP standards, and other best practices, quality standards and regulations; Google Cloud assists by offering reference architectures, GxP documentation, and intrinsic protections that exist in Google Cloud’s infrastructure.
Understanding that the Regulatory Submission Semantic QC Auditor must meet these needs, the solution is built on Google Cloud’s Gemini Enterprise, which provides robust, enterprise-grade privacy and security and controls architecture required. These include non-negotiable security pillars such as:
-
Data usage guarantee: Data Governance is essential with all Enterprises seeking assurance that its differentiated data remains private and protected. Customer data is not used to train Google models, nor is it used for advertising or shared with other customers; this is a core component for Intellectual Protection and proprietary research. More details about how Google processes data can also be found in Google’s Cloud Data Processing Addendum (CDPA).
-
Auditability: Immutable logging via Access Transparency and Cloud Logging for a comprehensive audit trail, which is necessary to support regulations such as 21 CFR Part 11. For more on ALCOA++ and data integrity on Google Cloud can be found here.
-
Access in Google Cloud: By utilizing logical security and predefined user roles, system access is restricted to authorized personnel according to specific business requirements. Identity and Access Management (IAM) provides granular control over every resource through enforcing the principle of least privilege.
How the Regulatory Submission Semantic QC Auditor Agent enhances your workflow
Think of the Regulatory Submission Semantic QC Auditor as an indefatigable, hyper-focused expert reviewer that works alongside your human team, catching errors they might miss and freeing them for higher-value work and overall increasing operational efficiency and outputs.
1. Intelligent ingestion and knowledge base creation The process begins by securely ingesting your diverse submission files—PDFs, Word documents, and data tables—along with relevant external regulatory guidance. The system parses and organizes this information, creating a unified, semantically searchable knowledge base that serves as the “brain” for all subsequent analysis.
2. Automated, multi-dimensional auditing Once ingested, the agent initiates a comprehensive series of checks. It performs semantic cross-referencing to ensure data integrity across modules and conducts dynamic compliance audits against the ingested guidance. It’s like having hundreds of pairs of eyes simultaneously reviewing every sentence and data point for consistency and compliance.
3. Actionable findings and Agentic remediation Instead of a simple list of errors, the system provides actionable insights. For every identified issue, it delivers a clear explanation, links directly to the conflicting sources in your documents, and, when prompted, generates a cited remediation plan. This allows your team to move quickly from problem detection to resolution, with confidence that their fixes are aligned with regulatory expectations.
Accelerating the path to patients: Operational efficiency through intelligent Quality Control
Adopting AI in a high-stakes domain like regulatory submissions requires a platform built on a foundation of security, transparency, accuracy, and control. Google Cloud’s Regulatory Submission Semantic QC Auditor provides the advanced AI capabilities to elevate the quality of your submissions, reduce regulatory risk, and empower your teams to bring groundbreaking therapies to patients faster.